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Interleukin-10 (IL-10) plays an indispensable role inmucosal tolerance by programming dendritic cells (DCs) to induce suppressor
Th-cells. We have tested the modulating effect of L. lactis secreting human IL-10 (L. lactisIL-10) on DC function in vitro. Monocyte-
derivedDC incubated with L. lactisIL-10 induced effector Th-cells thatmarkedly suppressed the proliferation of allogenic Th-cells as
compared to L. lactis. This suppressive effect was only seen when DC showed increased CD83 and CD86 expression. Furthermore,
enhanced production of IL-10 was measured in both L. lactisIL-10-derived DC and Th-cells compared to L. lactis-derived DC and
Th-cells. Neutralizing IL-10 during DC-Th-cell interaction and coculturing L. lactisIL-10-derived suppressor Th-cells with allogenic
Th-cells in a transwell system prevented the induction of suppressor Th-cells. Only 130 pg/mL of bacterial-derived IL-10 and 40
times more exogenously added recombinant human IL-10 were needed during DC priming for the generation of suppressor Th-
cells. The spatially restricted delivery of IL-10 by food-grade bacteria is a promising strategy to induce suppressor Th-cells in vivo
and to treat inflammatory diseases.
1. Introduction
The gastrointestinal mucosal immune system is continu-
ously balancing between tolerance towards nonpathogenic
bacteria and active immunity toward pathogenic bacteria
[1]. Animal models have clearly shown that IL-10 is an
important regulator in this context as IL-10 knock-out
mice develop chronic intestinal inflammation and IL-10
treatment is effective in several models of experimental
colitis [2–4]. Unfortunately, several clinical attempts to treat
inflammatory bowel disease using IL-10 have failed probably
due to low mucosal availability and proinflammatory effects
of high-dose systemic IL-10 administration [5–8]. The pro-
duction of human IL-10 by Lactococcus lactis (L. lactisIL-10)
could circumvent these problems. Indeed, L. lactisIL-10 is
effective in the prevention and treatment of colitis in animals,
and a phase-I clinical trial with L. lactisIL-10 in Crohn’s
disease patients suggested clinical benefit [9]. Dendritic
cells (DC) are regulators of the adaptive immune system
controlling both peripheral tolerance and immune activation
[10]. In the absence of pathogenic microorganisms, DC
are tuned by microenvironmental factors to induce and
maintain tolerance in the intestinal tract. This homeostatic
condition is critically controlled by cytokines including
IL-10 [11]. Culturing immature DC with IL-10 results
in Th-cell responses which suppress the proliferation of
allogenic Th-cells in a contact-dependent manner which is
not dependent on IL-10 production by (suppressor) Th-cells
[12]. We hypothesized that L. lactisIL-10 is able to modulate
immature DC to become regulatory DCwhich in turn induce
suppressor T cells.
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Figure 1: (a) Immature DC were matured with no bacteria, 1 × 105 cfu of viable L. lactisIL-10 or L. lactis in the presence of MF. Mature
DC were subsequently cultured with naı¨ve Th-cells to induce effector Th-cells which were harvested, washed, and stained with 3 × 10−5 M
PKH-26, a red cell-cycle tracking dye. Then, 2.5 × 104 effector Th-cells were preactivated overnight with anti-CD3 (1 : 5000) and anti-
CD28 (0.5mg/mL) in round-bottom 96-well plates. The following day allogenic (CD4+) Th-cells were labeled with CFSE, a green cell-cycle
tracking dye. After 5 days, the cellular content of CFSE in the allogenic Th-cells was analyzed by flow cytometry [13]. Depicted is the cell cycle
progression of allogenic Th-cells stimulated in the presence of MF derived effector Th-cells (white histograms, reference condition) and of
allogenic Th-cells cultured in the presence of MF/L. lactisIL-10 or MF/L. lactis derived effector Th-cells (gray histograms). (b) Depicted is the
mean inhibition of fluorescence intensity of allogenic Th-cells from five separate experiments for the indicated conditions. The proliferation
of allogenic Th-cells cultured in the presence of effector Th-cells derived from MF-matured DC which is regarded as 100% (reference
condition). Mean percentages with standard error of mean are given; ∗indicates P < 0.05 and ∗∗indicates P < 0.01 using the χ2-test for
comparing percentages with the reference condition (MF).
2. Materials and Methods
2.1. Bacterial Strains. For the generation of Lactococcus lactis
MG1363 IL-10 (L. lactisIL-10) and Lactococcus lactis MG1363
(L. lactis), the plasmid pOTHY12 was used (Lothar Steidler,
ActoGeniX, Belgium). The plasmid contains a 1 Kb region
including the constitutive thyA promoter (PthyA) from L.
lactis MG1363, the usp45 secretion leader, hIL-10, and a
1Kb region downstream of thyA gene. This leads to a
functional coupling of PthyA to usp45-hIL-10, expression
of the precursor, correct N-terminal processing of the
precursor, and secretion of mature hIL-10. In optimized in
vitro growth, L. lactis MG1363 pOTHY12 will produce in its
culture supernatant approximately 1 μg hIL-10 per 2 × 109
bacteria. For the generation of the negative control (L. lactis),
L. lactis MG1363 was transformed with an empty plasmid.
Both L. lactisIL-10 and L. lactis were grown overnight at 37◦C
(Elbanton incubator) in M17 broth (Difco) supplemented
with 0.5% glucose and 50 μg/mL erythromycin (Abbott,
Saint-Re´my-sur-Avre, France). Bacteria were diluted 1 : 50
in IMDM 5% FCS, grown for three hours at 37◦C, and
harvested at exponential growth phase (approximately 1 ×
107 cfu/mL).
2.2. Generation and Maturation of DC. All cultures were
performed in Iscove’s modified Dulbecco’s medium (IMDM)
with 1% FCS (HyClone, Logan, UT) and erythromycin
(50mg/mL, Abbott). Peripheral blood of healthy volunteers
was used to generate immature DC as earlier described [14].
Maturation was achieved at day 6 by adding 1 × 105 cfu bac-
teria with or without maturation factors (MF), recombinant
human (rh)-IL-1β (5 ng/mL; Boehringer Mannheim, Ger-
many), rh-TNF-α (25 ng/mL; PBH, Hannover, Germany),
and LPS (Sigma). After 4 hours, 50mL of supernatant was
harvested for measurement of bacterial IL-10 (ELISA; CLB,
Amsterdam, The Netherlands) and gentamycin (86 μg/mL,
Sigma) was added to kill all bacteria. On day eight, mature
DCs were harvested and washed, and cultures of DC on M17
agars confirmed that bacterial killing was complete. Mature
DCs were used for flow cytometry to assess maturation
by CD83 and CD86 expression or stimulated with one
of the following stimuli: IFN-γ (gift from Dr. P van
der Meide; U-Cy tech, Utrecht, The Netherlands) and/or
CD40L-transfected J558 plasmacytoma cells (gift from Dr. P.
Lane, Birmingham Medical School, Birmingham, UK). After
48 hours, supernatants were used for cytokine detection
using ELISA for IL12p70 (R&D Systems, detection limit
31.2 pg/mL) and IL-10 (CLB, detection limit 31.2 pg/mL).
2.3. T-Cell Instruction by Mature DC. Mature DC (5 ×
103 cells/200 μL) were incubated with 2.5 × 104 purified
CD4+CD45RA+CD45RO− naı¨ve T cells (>90% as assessed
by flow cytometry) from PBMC using MACS separation
system (Miltenyi Biotec, Germany). When indicated rat-
antihuman IL-10 neutralizing IgG1 (1 : 1000, BD Pharmin-
gen, San Jose, Calif, USA) antibodies were added, purified
rat IgG1 (BD Pharmingen) was used as isotype control.
Th-cells were further expanded and stimulated with solu-
ble mouse antihuman-CD3 and mouse antihuman-CD28
(both CLB). After 48 hours, supernatants were used for
cytokine detection using ELISA for IFN-γ (R&D Systems,
detection limit 31.2 pg/mL) and IL-10 (CLB). Moreover,
expanded Th-cells were used in a Th-cell coculture model
to assess suppressor function of DC-derived Th-cells [15].
In short, expanded (effector) Th-cells were cultured with
CD4+ (autologous) T cells and T-cell proliferation was
measured using cell-cycle tracking dyes; cell division results
in decreased fluorescence intensity of separate cells. The
fluorescence intensity of allogenic T cells, after culture with
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Figure 2: (a) Immature DCs were not matured (grey histogram), matured with 1× 105 cfu viable L. lactisIL-10 (continuous line), or matured
with MF and 1 × 105 cfu viable L. lactisIL-10 (dotted line). CD83 (left panel) and CD86 (right panel) expression was assessed after 48 hours
by flow cytometry. (b) Immature DCs were primed with MF or 1× 105 cfu viable L. lactisIL-10 with and without MF. Depicted is the cell cycle
progression of allogenic Th-cells co-cultured with effector Th-cells derived from MF-matured DC is regarded as 100% (white histograms,
reference condition) and the cell cycle progression of allogenic Th-cells cocultured with effector Th-cells derived from L. lactisIL-10 (left
panel) or L. lactisIL-10 /MF-(right panel) matured DC (gray histograms).
effector T cells derived from MF-matured DC, was taken as
100% (reference condition).
2.4. Statistics. For comparison of cytokine production, a het-
eroscedastic Student t-test was performed, while for compar-
ison of percentages, a X2-test for comparing percentages was
performed. When multiple groups were present a Kruskall-
Wallis One-Way Analysis of Variance was performed (SPSS,
version 11.01, Chicago, Ill, USA). Statistical significance was
defined as a P < 0.05, confidence interval 95%.
3. Results
3.1. L. lactis(IL-10) Matures DC to Promote the Development
of Suppressor T Cells. DCs were matured in presence of
MF or MF with bacteria (L. lactis or L. lactisIL-10) and
used to differentiate naı¨ve Th-cells into effector Th-cells.
Subsequently, the generated effector Th-cells were analyzed
for their effect on Th-cell proliferation in a coculture model
[15]. The fluorescence intensity of allogenic Th-cells after
culture with effector Th-cells derived from MF-matured DC
was taken as 100% (reference condition). Effector Th-cells
generated by MF/L. lactis-DC allowed the proliferation of
67% of all allogenic Th-cells (Figure 1(a)), while effector
Th-cells generated by MF/L. lactisIL-10 -DC only allowed
proliferation of 42% of all allogenic Th-cells (Figure 1(a)).
The mean proliferation from five separate experiments was
72% (P < 0.05) and 42% (P < 0.01) for L. lactis and L.
lactisIL-10, respectively, indicating that IL-10 production by
L. lactis significantly improved the suppression of allogenic
Th-cells proliferation by effector Th-cells (Figure 1(b)).
3.2. The Induction of Suppressor Th-Cells by L.
lactis IL-10 Matured DC Is Dependent on Full Maturation of
DC. DC matured with L. lactisIL-10 in the absence of MF
showed a minimal increase in the expression of CD83 and
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Figure 3: (a) Immature DCs were not matured, matured with MF or with 1 × 105 cfu of viable L. lactis, L. lactisIL-10, L. lactisIL-10 /α-IL-10,
or L. lactisIL-10 /rat IgG1 in the presence of MF. Mature DCs were harvested after 48 hours, washed, and restimulated (2 × 104 cells in 200 μL)
for 48 hours with CD40L transfected irradiated hybridoma cells to assess IL-10 production or in combination with IFN-γ to asses IL-12p70
production. Mean values with standard error of mean are given; ∗ indicates P < 0.05 and ∗∗indicates P < 0.01 using heteroscedastic Student
t-test. (b) Immature DCs were not matured, matured with MF or with 1× 105 CFU of viable L. lactis, L. lactisIL-10, L. lactisIL-10 /α-IL-10 or L.
lactisIL-10 /rat IgG1 in the presence of MF. Mature DCs were subsequently cultured with naı¨ve Th-cells for 5 days, these DC derived Th-cells
were washed and restimulated with CD3/CD28 (100.000 cell/200 μL, final concentration 1 : 1000) to assess IL-10 and IFN-γ production.
Mean values with standard error of mean are given; ∗∗indicates P < 0.01 using heteroscedastic Student t-test.
CD86 as expressed by mean fluorescence intensity. When
MFs were added during maturation with L. lactisIL-10 a
strong upregulation of CD83 and CD86 was observed as
can be seen in the histograms (Figure 2(a)). Compared
to the reference condition, DC matured in the absence of
MF but in the presence of L. lactisIL-10 -induced effector
Th-cells that were not able to significantly suppress naive
T-cell proliferation. On the contrary when MF was added
together with L. lactisIL-10 during DC maturation, these
DCs were able to induce effector Th-cells that efficiently
reduced the proliferation of naı¨ve T cells. Hence, lower
expression of CD83 and CD86 in L. lactisIL-10 matured DC
was associated with a marked reduction in their ability to
induce effector Th-cells with suppressive effects on allogenic
Th-cell proliferation (Figure 2(b)).
3.3. L. lactis IL-10 Matures DC to Produce IL-10 and Induces
IL-10 Producing Th-Cells. L. lactisIL-10 and L. lactis, in com-
bination with MF, were used to mature DC. After 4 hours,
bacteria were killed with antibiotics, and after 48 hours,
mature DCs were restimulated with CD40L or CD40L/IFN-γ
to assess IL-10, IL-12p70, and IL-6 production, respectively.
DC produced 3200 pg/mL and 1600 pg/mL IL-10 after
maturation with L. lactisIL-10 and L. lactis, respectively, (P <
0.05, compared to L. lactis, Figure 3(a)). The production of
IL-12p70 (Figure 3(a)) and IL-6 (data not shown) was not
significantly different between the groups. Furthermore, IL-
10 and IFN-γ production by effector Th-cells, induced by the
different DC groups, was measured. Maturation of DC with
L. lactisIL-10 or L. lactis in combination with MF resulted in
the induction of effector Th-cells that produced 2400 pg/mL
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Figure 4: (a) Depicted is the cell cycle progression of allogenic Th-cells cocultured with MF-derived effector Th-cells (white histograms,
reference condition) and of allogenic Th-cells cocultured with effector Th-cells when no α-IL-10 was added (no α-IL-10), α-IL-10 during
DC-naı¨ve T-cell (α-IL-10 DC-T) coculture or α-IL-10 during effector T-cell and allogenic T-cell (α-IL-10 T-T) coculture (gray histograms).
(b) Bar graphs represent the mean inhibition of fluorescence intensity of allogenic Th-cells for the indicated conditions in triplicate. The
proliferation of allogenic Th-cells cocultured with effector Th-cells induced by MF-matured DC is regarded as 100% (reference condition).
For transwell experiments, 2 × 106 PKH-labeled test cells were put in the upper compartment of a 24-well plate transwell system. Mean
percentages with standard error of mean are given; ∗∗indicates P < 0.01 using the χ2-test for comparing percentages with the reference
condition (α-IL-10 DC-T and transwell, resp.).
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Figure 5: Immature DC primed with MF/L. lactis and increasing
amounts of recombinant human IL-10 (0, 0.5, 5 and 50 ng/mL).
Bar graphs represent the mean inhibition of fluorescence intensity
of allogenic Th-cells for the indicated conditions in duplo. The
proliferation of allogenic Th-cells cocultured with effector Th-
cells derived from MF-matured DC is regarded as 100% (reference
condition). Mean percentages with standard error of mean are
given; ∗indicates P < 0.05 and ∗∗indicates P < 0.01 using the χ2-
test for comparing percentages with the reference condition (MF).
and 700 pg/mL IL-10, respectively, (P < 0.01, compared
to L. lactis, Figure 3(b)). The production of IFN-γ was
not significantly different between the groups (Figure 3(b)).
Finally, the addition of neutralizing IL-10 antibodies during
maturation of immature DC with L. lactisIL-10 significantly
reversed the production of IL-10 by mature DC and effector
Th-cells (P < 0.01, compared to isotype control, Figures 3(a)
and 3(b)).
3.4. IL-10 Is Important for the Induction But Not for the
Function of Suppressor Th-Cells. Neutralizing IL-10 during
coculture of L. lactisIL-10 -matured DC and naı¨ve Th-cells
completely abrogated the suppressive effect of effector Th-
cells on allogenic Th-cell proliferation (Figure 4(a)). How-
ever, neutralizing IL-10 during coculture of L. lactisIL-10 -
derived suppressor Th-cells and allogenic Th-cells did not
affect the suppressive effect on allogenic Th-cell proliferation
(P < 0.01, compared to MF, Figure 4(b)). Also, neutralizing
TGF-β or CTLA-4 costimulation did not affect the suppres-
sive effect of L. lactisIL-10 -derived suppressor Th-cells on
allogenic Th-cells proliferation (P < 0.01, compared to MF,
Figure 4(b)). Finally, the suppression of L. lactisIL-10 -derived
suppressor Th-cells on allogenic Th-cell proliferation was
completely abrogated by physical separation of suppressor
and allogenic Th-cells (Figure 4(b)).
3.5. Efficient Delivery of Bacterial-Derived IL-10 to DC. An
amount of 105 cfu of L. lactisIL-10 produced 85 pg/mL of IL-
10 in the absence of DC (data not shown). After 4 hours,
supernatants from DC cultured with viable L. lactisIL-10
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and MF contained 130 pg/mL (data not shown). Increas-
ing amount of recombinant human IL-10 (500 pg/mL,
5000 pg/mL, and 50.000 pg/mL) during DC cultures with
viable L. lactis andMF increased the suppressive effect of DC-
derived effector Th-cells on allogenic Th-cell proliferation
to 67.5% (P < 0.05, compared to MF), 46.5% (P < 0.01,
compared to MF), and 48.5% (P < 0.01, compared to MF),
respectively, (Figure 5).
4. Discussion
The effective ability of DC to initiate different types of Th-
cell responses makes this cell type an important target for
innovative strategies requiring either polarized immunity
(i.e., in vaccination or cancer) or tolerance (i.e., in chronic
inflammatory, autoimmune, or allergic diseases) [16]. The
immunoregulatory cytokine IL-10 plays a central role in the
induction and maintenance of mucosal tolerance through
the induction of regulatory DC [1]. However, IL-10 treat-
ment in humans with colitis is disappointing due to low
mucosal availability and proinflammatory effects at higher
doses of IL-10 [7]. We hypothesized that L. lactisIL-10 is able
to modulate DC to become regulatory DC which in turn
induce suppressor T cells. To this aim, we cultured viable L.
lactis and L. lactisIL-10 with DC and assessed the effect of DC-
derived effector Th-cells on allogenic Th-cell proliferation
in the absence of DC and bacteria. We observed that L.
lactis can imprint a regulatory DC phenotype which is even
more pronounced by secretion of IL-10. The final suppressive
effect on Th-cell proliferation is probably in part due to
the intrinsic immunomodulatory effect of L. lactis and in
part due to the presence of IL-10 during DC maturation. L.
lactis has much homology with several probiotic organisms
that are known to induce regulatory immune responses [15,
17, 18]. We had to culture L. lactisIL-10 (temporarily) alive
to allow IL-10 production and secretion. Hence, secreted
bacterial factors could also have modulated the maturation
process, phenotype, and suppressor function of DC. The
immunomodulatory effect of IL-10 during priming of DC
in our model is in accordance with the findings of other
groups [19, 20]. Interestingly, low levels of IL-10 produced by
L. lactisIL-10 during DC maturation are sufficient to induce
regulatory DC. L. lactisIL-10 produced around 130 pg/mL
IL-10 before antibiotics were added, and we needed up to
5000 pg/mL of rh-IL-10 to produce comparable suppressive
effects. Thus, approximately 40 times more IL-10 during
DC priming was needed to induce suppressor Th-cells,
suggesting that spatially restricted bacterial IL10 is more
efficient than soluble IL-10 for the induction of regulatory
DC. It would be interesting to establish if this phenomenon
is also occurring in vivo and if other factors like bacterial
translocation across the epithelium and physical contact with
DC in the lamina propria and/or mesenteric lymph node are
necessary for inducing these suppressor immune responses
[21].
The induction of regulatory DC by L. lactisIL-10 was
characterized by full maturation, high production of IL-10,
and low production of IL-12p70 and IL-6. Moreover, IL-10
is required for the induction of suppressor Th-cells by DC
but not for the suppressive function of suppressor Th-cells
during coculture with allogenic Th-cells. The function of
IL-10 production by suppressor Th-cells cannot be deduced
from our experiments, but it might be important for the per-
sistence of regulatory immune responses through feedback
on newly recruited immature DC in the periphery in vivo
[22]. Unfortunately, we were not able to identify the driving
factor behind the suppressor effect of Th-cell induced by L.
lactisIL-10 during T-T cell interaction. Both IL-10 and TGF-
βare not involved in the suppressive effect of effector Th-
cells on naı¨ve T-cell proliferation. The transwell experiment
suggests that contact-dependent factors are important, but
CTLA-4 was ruled out by using a blocking antibody. Hence,
other contact-dependent factors like ICAM-3 and GITR
might be important in these effector Th-cells induced by L.
lactisIL-10 [15, 23]. It is an attractive idea to suggest that foxp3
might play an important role in the induction of suppressor
Th-cells by L. lactisIL-10 -matured DC, but we have not yet
been able to prove such a relationship [24].
In conclusion, our data indicate that the observed anti-
inflammatory effect of L. lactisIL-10 is mediated through
modulation of DC function. The utilization of L. lactis
for delivery of proteins has several advantages including
increased mucosal availability, ease of administration, lower
therapeutic doses, and cost effectiveness. This strategy might
be applicable in the treatment of inflammatory and infec-
tious diseases [13, 25, 26].
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